Follow
Majid Marjani
Majid Marjani
Verified email at sbmu.ac.ir
Title
Cited by
Cited by
Year
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
4222021
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3162021
Diabetes mellitus and tuberculosis facts and controversies
P Baghaei, M Marjani, P Javanmard, P Tabarsi, MR Masjedi
Journal of Diabetes & Metabolic Disorders 12, 1-8, 2013
2192013
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
1242022
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance
M Shamaei, M Marjani, E Chitsaz, M Kazempour, M Esmaeili, P Farnia, ...
International Journal of Infectious Diseases 13 (5), e236-e240, 2009
1102009
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
P Tabarsi, S Barati, H Jamaati, S Haseli, M Marjani, A Moniri, Z Abtahian, ...
International immunopharmacology 90, 107205, 2021
962021
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
F Dastan, SA Nadji, A Saffaei, M Marjani, A Moniri, H Jamaati, ...
International immunopharmacology 85, 106688, 2020
902020
Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases
P Baghaei, P Tabarsi, E Chitsaz, M Saleh, M Marjani, S Shemirani, ...
American journal of therapeutics 17 (1), 17-22, 2010
872010
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial
H Jamaati, SMR Hashemian, B Farzanegan, M Malekmohammad, ...
European Journal of Pharmacology 897, 173947, 2021
842021
Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran
P Baghaei, P Tabarsi, D Dorriz, M Marjani, M Shamaei, MV Pooramiri, ...
American journal of therapeutics 18 (2), e29-e34, 2011
812011
Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis—need for earlier identification of nontuberculosis mycobacteria
P Tabarsi, P Baghaei, P Farnia, N Mansouri, E Chitsaz, F Sheikholeslam, ...
The American journal of the medical sciences 337 (3), 182-184, 2009
752009
Increased serum levels of soluble TNF-α receptor is associated with ICU mortality in COVID-19 patients
E Mortaz, P Tabarsi, H Jamaati, N Dalil Roofchayee, NK Dezfuli, ...
Frontiers in Immunology 12, 592727, 2021
682021
Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency
P Tabarsi, M Marjani, N Mansouri, P Farnia, S Boisson-Dupuis, ...
Journal of clinical immunology 31, 537-539, 2011
652011
Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm
S Mahmoudi, M Rezaei, N Mansouri, M Marjani, D Mansouri
Journal of clinical immunology 40, 974-976, 2020
642020
Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial
F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ...
International immunopharmacology 88, 106869, 2020
632020
Pulmonary disease caused by Mycobacterium simiae in Iran’s national referral center for tuberculosis
P Baghaei, P Tabarsi, P Farnia, M Marjani, FM Sheikholeslami, M Chitsaz, ...
The Journal of Infection in Developing Countries 6 (01), 23-28, 2012
572012
Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients
FS Beigee, MP Toutkaboni, N Khalili, SA Nadji, A Dorudinia, M Rezaei, ...
Pathology-Research and Practice 216 (10), 153228, 2020
512020
A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol
H Jamaati, F Dastan, P Tabarsi, M Marjani, A Saffaei, SMR Hashemian
Iranian Journal of Pharmaceutical Research: IJPR 19 (1), 31, 2020
512020
Rumen fermentation and microbial community composition influenced by live Enterococcus faecium supplementation
LL Mamuad, SH Kim, AA Biswas, Z Yu, KK Cho, SB Kim, K Lee, SS Lee
Amb Express 9 (1), 123, 2019
50*2019
Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study
P Tabarsi, P Baghaei, M Marjani, WM Vollmer, MR Masjedi, AD Harries
Journal of Diabetes & Metabolic Disorders 13, 1-6, 2014
502014
The system can't perform the operation now. Try again later.
Articles 1–20